Tabula Rasa HealthCare, Inc. revised preliminary revenue guidance for the fourth quarter 2022 . Revenue from continuing operations for the fourth quarter of 2022 is expected to be between $82 $83 million, exceeding the prior guidance range of $77.5 $80.5 million.
Tabula Rasa HealthCare, Inc.
Equities
TRHC
US8733791011
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+6.23% | 33.06B | |
+20.73% | 7.99B | |
+34.25% | 4.34B | |
-29.94% | 2.62B | |
-12.76% | 1.46B | |
-27.55% | 1.31B | |
-30.53% | 1.21B | |
+11.30% | 993M | |
-38.17% | 883M |